Clinical trials
Multiple Trauma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 6 |
| Recruiting | 3 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital Ostrava | 2 |
| VA Office of Research and Development | 2 |
| A.O. Ospedale Papa Giovanni XXIII | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Assiut University | 1 |
| Baylor College of Medicine | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Columbia University | 1 |
| Faculdade de Medicina do ABC | 1 |
| Indonesia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Trauma | 26 |
| Wounds and Injuries | 9 |
| Brain Injuries, Traumatic | 3 |
| Shock, Hemorrhagic | 3 |
| Stress Disorders, Post-Traumatic | 3 |
| Accidental Injuries | 2 |
| Agnosia | 2 |
| Brain Injuries | 2 |
| Burns | 2 |
| Critical Illness | 2 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.